Skip to content

Evaluation of the Impact of Remimazolam Tosylate on Cardiac Function during Anesthesia Induction and Maintenance in Patients Undergoing Abdominal Surgery Based on Transesophageal Echocardiography

Evaluation of the Impact of Remimazolam Tosylate on Cardiac Function during Anesthesia Induction and Maintenance in Patients Undergoing Abdominal Surgery Based on Transesophageal Echocardiography

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500107159
Enrollment
Unknown
Registered
2025-08-05
Start date
2025-08-31
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General anesthesia for abdominal surgery

Interventions

Remimazolam Tosylate Group:Sedation with remimazolam tosylate

Sponsors

Zigong Fourth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. 18 years old = 3 days. 6. Patients undergoing elective abdominal surgery

Exclusion criteria

Exclusion criteria: 1. Emergency surgery or elective surgery with a duration of = 160 mmHg and/or diastolic blood pressure >= 100 mmHg); 3. abnormal laboratory test results (anemia: Hb = 2.5 × ULN, TBIL >= 1.5 × ULN; abnormal renal function: serum creatinine higher than the upper limit of normal); 4. acute angle-closure glaucoma, myasthenia gravis, acute alcohol intoxication; 5. patients with shock (systolic blood pressure <= 90 mmHg) or coma; 6. patients allergic or resistant to benzodiazepines; 7. pregnant or lactating women; 8. patients requiring cardiopulmonary bypass, hepatectomy or liver transplantation; patients who have participated in other drug clinical trials as 9.subjects within the past 3 months; 10. patients deemed unsuitable for this trial by the researcher, or patients who refuse to participate themselves; 11. patients with contraindications to TEE: known esophageal stricture, obstruction, spasm, diverticulum, dysphagia, large hiatal hernia, tumors or varices/bleeding of the esophagus and stomach, history of esophageal surgery, and intestinal volvulus.

Design outcomes

Primary

MeasureTime frame
Left ventricular stroke volume;

Secondary

MeasureTime frame
Cardiac output;Left ventricular shortening fraction;Left ventricular ejection fraction;

Countries

China

Contacts

Public ContactLu Bin

Zigong Fourth People's Hospital

binludoctor@126.com+86 139 9004 4633

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026